{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "17629327", "DateCompleted": {"Year": "2007", "Month": "10", "Day": "04"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2007", "Month": "07", "Day": "13"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0163-3864", "JournalIssue": {"Volume": "70", "Issue": "8", "PubDate": {"Year": "2007", "Month": "Aug"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Hydroxyalkenylresorcinols from Stylogyne turbacensis.", "Pagination": {"StartPage": "1249", "EndPage": "1252", "MedlinePgn": "1249-52"}, "Abstract": {"AbstractText": ["Two new compounds, 5-(11'(S)-hydroxy-8'-heptadecenyl)resorcinol (3) and 5-(12'(S)-hydroxy-8',14'-heptadecadienyl)resorcinol (4), were isolated from the leaves of Stylogyne turbacensis together with the known analogue metabolites 1 and 2. Compounds 3 and 4 showed the strongest activity in the leishmania assay, 7 and 3 microM, respectively, while compounds 1, 2, and 4 showed moderate activity against a drug-resistant strain of Trypanosoma cruzi with IC(50) values of 30, 25, and 22 microM, respectively. Additional testing in MCF-7 and NCI-H460 was performed for compounds 3 and 4. The structures of compounds 1-4 were elucidated using NMR, MS, and other spectroscopic data. The absolute stereochemistry of compounds 3 and 4 was also investigated using the Mosher ester approach. Peracetylated derivatives of these four metabolites were produced and their activities determined in the Trypanosoma cruzi assay."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Tropical Bioorganic Chemistry, Faculty of Natural, Exact Sciences and Technology, Apartado 0824-10835, University of Panama, Panama City, Republic of Panama."}], "Identifier": [], "LastName": "Jim\u00e9nez-Romero", "ForeName": "Carlos", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Torres-Mendoza", "ForeName": "Daniel", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ure\u00f1a Gonz\u00e1lez", "ForeName": "Luis David", "Initials": "LD"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ortega-Barr\u00eda", "ForeName": "Eduardo", "Initials": "E"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "McPhail", "ForeName": "Kerry L", "Initials": "KL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gerwick", "ForeName": "William H", "Initials": "WH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cubilla-Rios", "ForeName": "Luis", "Initials": "L"}], "GrantList": [{"GrantID": "1U01 TW 006634-01", "Acronym": "TW", "Agency": "FIC NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, U.S. Gov't, Non-P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "5-(11'(S)-hydroxy-8'-heptadecenyl)resorcinol"}, {"RegistryNumber": "0", "NameOfSubstance": "5-(12'(S)-hydroxy-8',14'-heptadecadienyl)resorcinol"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiprotozoal Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Resorcinols"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antiprotozoal Agents"}, {"QualifierName": [], "DescriptorName": "Chlorocebus aethiops"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Leishmania"}, {"QualifierName": [], "DescriptorName": "Nuclear Magnetic Resonance, Biomolecular"}, {"QualifierName": [], "DescriptorName": "Panama"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Primulaceae"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Resorcinols"}, {"QualifierName": ["drug effects"], "DescriptorName": "Trypanosoma cruzi"}, {"QualifierName": [], "DescriptorName": "Vero Cells"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2007", "Month": "7", "Day": "17", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "10", "Day": "5", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "7", "Day": "17", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["17629327", "10.1021/np070081d"]}}], "PubmedBookArticle": []}